IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading pet healthcare company, on Monday reported an increase in revenue and net income for the second quarter of fiscal 2025.
- Second-quarter revenue increased to $1.11 billion from $1.0 billion in the prior-year quarter, up 11%
- On an organic basis, revenue grew 9%, supported by CAG diagnostics recurring revenue growth of 9% as reported and 7% organic
- Net income was $294.0 million in Q2 2025, compared to $203.3 million in the prior-year quarter
- Earnings, on a per-share basis, climbed 49% year-over-year to $3.63 in Q2; EPS grew 17% on a comparable basis
- The management raised its full-year revenue guidance to $4,205-4,280 million, an increase of $90 million or around 2% at midpoint
- The guidance for full-year reported revenue growth is 7.7-9.7%; CAG diagnostics recurring revenue growth is expected to be 6.5-8.7%
- It expects full-year earnings to be in the range of $12.40 per share to $12.76 per share
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to